NCT05502458
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Zhejiang Cancer hospital Hangzhou, Zhejiang, China
Clinical trial condition
Explore clinical trials studying Desflurane Adverse Reaction. Study availability and eligibility vary by location and protocol.
NCT05502458